“amgen” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
In RNAi Move, Takeda Fronts $300M to Team Up on Arrowhead Liver Drug 10/08/20 National
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Reeling From FDA Rejection, Intercept Pharma Slashes Headcount by 25% 09/01/20 New York
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire 07/21/20 San Francisco
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs 05/28/20 Seattle
BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info 05/13/20 New York
QurAlis Hauls In $42M to Move New ALS Therapies Into Human Testing 05/13/20 Boston
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
Akero Heads to Top of Class in NASH; Genfit Says Pandemic Won’t Delay Data 04/10/20 National
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Fears Of Recession Mount As Coronavirus Declared A Pandemic 03/19/20 National
Takeda Bases PvP Biologics Buyout on Promising Early Celiac Drug Data 02/26/20 San Diego
Esperion’s FDA-Approved Cholesterol Drug Priced Even Lower Than Expected 02/24/20 Detroit Ann Arbor
Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug 02/23/20 National
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Mirati Adds Execs With Commercial Experience at Spark, Bristol-Myers 01/08/20 San Diego
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines 12/24/19 National
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning 12/12/19 National
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund 11/06/19 National
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own 10/15/19 New York
Page 1 of 22 next page »